SOUTH AFRICA
The number of drug-resistant tuberculosis (TB) cases is exploding in South Africa, according to Action TB, a research group funded by the British pharmaceuticals company Glaxo Wellcome. The Kwazulu-Natal region alone has witnessed a 300 per cent rise in the number of multidrug-resistant TB cases in just one year. "The extent of this increase is new and very worrying," says Ken Duncan, head of Action Tit. According to the researchers, one in 10 Cases of TB is resistant to treatment in some parts of South Africa.
Related Content
- Global LNG outlook 2024-2028
- Empowering women for effective climate change adaptation: the role of the private sector
- Blackouts and backsliding: energy subsidies in South Africa 2023
- Funding a tuberculosis-free future: an investment case for screening and preventive treatment
- Costs of health care associated infections from inadequate water and sanitation in health care facilities in Eastern and Southern Africa
- Donkeys in global trade: wildlife crime, welfare, biosecurity and the impact on women